Evidence map›Paper›PMID 34716688›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

High-Throughput and Dosage-Controlled Intracellular Delivery of Large Cargos by an Acoustic-Electric Micro-Vortices Platform.

Mohammad Aghaamoo, Yu-Hsi Chen, Xuan Li, Neha Garg, Ruoyu Jiang, Jeremy Tian-Hao Yun, Abraham Phillip Lee

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Advancing Allogeneic NK Cell Immunotherapy through Microfluidic Gene Delivery.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Three-dimensional array of microbubbles sonoporation of cells in microfluidics.Frontiers in bioengineering and biotechnology · 2024
    Article
  14. Article
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Mohammad AghaamooDepartment of Biomedical Engineering, University of California Irvine, Irvine, CA, 92697, USA.ORCID 0000-0002-4081-6763
Yu-Hsi ChenDepartment of Biomedical Engineering, University of California Irvine, Irvine, CA, 92697, USA.
Xuan LiDepartment of Biomedical Engineering, University of California Irvine, Irvine, CA, 92697, USA.
Neha GargDepartment of Biomedical Engineering, University of California Irvine, Irvine, CA, 92697, USA.
Ruoyu JiangDepartment of Biomedical Engineering, University of California Irvine, Irvine, CA, 92697, USA.ORCID 0000-0002-9499-1129
Jeremy Tian-Hao YunDepartment of Biomedical Engineering, University of California Irvine, Irvine, CA, 92697, USA.
Abraham Phillip LeeDepartment of Biomedical Engineering, University of California Irvine, Irvine, CA, 92697, USA.ORCID 0000-0001-8378-6616

Funding

University of California Health Participation in the National COVID Cohort Collaborative (N3C)UL1TR001414 · NCATS · UNIVERSITY OF CALIFORNIA-IRVINE · PI COOPER, DAN M, VILAIN, ERIC J. · 2015 to 2023
$35.1M
Center for Advanced Design and Manufacturing of Integrated Microfluidics IIP 1841509National Science FoundationNCATS NIH HHS UL1 TR001414
6 · The paper itself

Abstract

A high-throughput non-viral intracellular delivery platform is introduced for the transfection of large cargos with dosage-control. This platform, termed Acoustic-Electric Shear Orbiting Poration (AESOP), optimizes the delivery of intended cargo sizes with poration of the cell membranes via mechanical shear followed by the modulated expansion of these nanopores via electric field. Furthermore, AESOP utilizes acoustic microstreaming vortices wherein up to millions of cells are trapped and mixed uniformly with exogenous cargos, enabling the delivery of cargos into cells with targeted dosages. Intracellular delivery of a wide range of molecule sizes (<1 kDa to 2 MDa) with high efficiency (>90%), cell viability (>80%), and uniform dosages (<60% coefficient of variation (CV)) simultaneously into 1 million cells min

Indexed as

Gene Transfer TechniquesAcousticsCell Line, TumorGene EditingHumansCRISPR-Cas9intracellular deliverylarge cargoprecise-dose delivery

Identifiers

PMID34716688
PMCPMC8728830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.